OHSU research suggests initial placement of defibrillator pads could make a significant difference in returning spontaneous blood circulation for patients in cardiac arrest. Lead author Joshua Lupton, M.D., a cardiac arrest survivor, says, “The less time that you’re in cardiac arrest, the better. The longer your brain has low blood flow, the lower your chances of having a good outcome.”

Story about the FDA’s recent approval of a new blood test to detect colorectal cancer. David Lieberman, M.D., says, “Detecting circulating-free DNA associated with [colorectal cancer] in blood is a major scientific breakthrough. The ease of blood testing will appeal to patients and providers."

MD Edge interviews experts about the FDA’s recent approval of a new blood test to detect colorectal cancer. David Lieberman, M.D., says, “Detecting circulating-free DNA associated with [colorectal cancer] in blood is a major scientific breakthrough. The ease of blood testing will appeal to patients and providers.”

A PR Newswire release from Beacon Therapeutics highlights a presentation by Paul Yang, M.D., Ph.D., regarding interim results from a clinical trial involving patients with X-linked retinitis pigmentosa.

In a Globe Newswire release about positive results of two phase 3 studies of a once-daily, steroid-free treatment for mild to moderate atopic dermatology, Eric Simpson, M.D., says, “AD is a chronic and burdensome disease that often leaves patients and caregivers searching for relief from intractable itch, the most reported symptom which leads to reduced quality of life and sleep disturbance.”

In a Globe Newswire release about positive results of two phase 3 studies of a once-daily, steroid-free treatment for mild to moderate atopic dermatology, Eric Simpson, M.D., says, “AD is a chronic and burdensome disease that often leaves patients and caregivers searching for relief from intractable itch, the most reported symptom which leads to reduced quality of life and sleep disturbance.”

Yahoo!News republishes KOIN-TV story about a new OHSU-led study that finds telehealth boosts retention for addiction treatment. In an OHSU News story, Brian Chan, M.D., says, “This finding reinforces the idea that telehealth is effective in starting and continuing treatment for people with opioid use disorders.”

In a Portland Business Journal story about a $68 million investment round related to a compound that grew out of research initially done by Marc Freeman, Ph.D., he says, “If it works, it could have broad effects and help a number of patients.”

OPB-Radio reports that OHSU is among the locations where people can get the RSV vaccine.

OHSU has opened a centralized Mission Control center — the first time since the coordinating effort launched in 2017 that all of the technology and teams have been in one centralized location. Matthias Merkel, M.D., Ph.D., says, “Now we are instead working with unprecedented collaboration, better connecting Oregon’s health services, improving access for Oregonians, and supporting clinicians at every level of care through OMCC and OBCC.”